Elsevier

Developmental Biology

Volume 232, Issue 2, 15 April 2001, Pages 471-483
Developmental Biology

Regular Article
Analysis of Melanocyte Precursors in Nf1 Mutants Reveals That MGF/KIT Signaling Promotes Directed Cell Migration Independent of Its Function in Cell Survival

https://doi.org/10.1006/dbio.2001.0167Get rights and content
Under an Elsevier user license
open archive

Abstract

Neural crest-derived melanocyte precursors (MPs) in avian and murine embryos emerge from the dorsal neural tube into a migration staging area (MSA). MPs subsequently migrate from the MSA on a dorsolateral pathway between the dermamyotome and the overlying epithelium. In mouse embryos, MPs express the receptor tyrosine kinase, KIT, and require its cognate ligand, Mast cell growth factor (MGF), for survival and differentiation. Prior to the onset of MP migration, MGF is expressed on the dorsolateral pathway at some distance from cells in the MSA and appears to be required for normal MP development. To learn if MGF is required solely for MP survival on this pathway, or if it also provides directional cues for migration, we uncoupled survival from chemoattractive or motogenic functions of this ligand using mice that carry a targeted mutation at the Neurofibromin (Nf1) locus and consequently lack RAS-GAP function. We show that Nf1-mutant MPs survive in the absence of MGF in vitro and in vivo and that Nf1-mutant MPs disperse normally on the lateral migration pathway in the presence of MGF. In contrast, Nf1-mutant MPs persist in the location of the MSA but are not observed on the lateral migration pathway in double-mutant mice that also lack MGF. We conclude that MGF/KIT function provides a signal required for directed migration of the MPs on the lateral pathway in vivo, independent of its function in survival. We further suggest that the MGF mediates MP migration through a signaling pathway that does not involve RAS.

Keywords

neural crest
cell migration
chemoattraction
neurofibromin
RAS-GAP

Cited by (0)

1

Present address: Department of Pathology, University of Geneva, 1 Rue Michel-Servet, 1211 Geneva 4, Switzerland.

2

Present address: Targeted Genetics, 1100 Olive Way, Suite 100, Seattle, WA 98101.

3

To whom correspondence should be addressed at the Institute of Neuroscience, 1254 University of Oregon, Eugene, OR 97403-1254. Fax: (541) 346-4548. E-mail: [email protected].